CDC recommends new treatment for latent tuberculosis

Share this article:

The Centers for Disease Control and Prevention has recommended a new 12-week-long treatment for latent tuberculosis, which is easier to carry out and as effective as existing treatments.

The standard treatment for latent tuberculosis, an asymptomatic version of the respiratory infection, involves nine months of daily doses of the antibiotic isoniazid. Experts say only 60% of patients complete the medication regime.

A CDC report says studies have shown that 12 weekly doses of isoniazid with another antibiotic, rifapentine, is equally as effective under the supervision of a healthcare worker.

Experts say that roughly 11.2 million Americans have latent tuberculosis infections. CDC researchers say they are targeting prevention efforts to high-risk populations, such as the elderly, healthcare workers, and those with underlying conditions such as diabetes, the New York Times reports.
Share this article:

More in News

Genesis, Skilled Healthcare merger to create huge long-term care provider with more than 500 facilities

Genesis, Skilled Healthcare merger to create huge long-term ...

Genesis HealthCare and Skilled Healthcare Group Inc. will merge to create a single long-term and post-acute care company with more than 500 facilities nationwide, the providers announced Tuesday.

Antipsychotic use tied to acute kidney injury, increasing pressure on nursing home ...

Older people who take antipsychotic medications are at a markedly increased risk of acute kidney injury, according to newly published research findings out of Canada. The study further supports ongoing efforts to reduce the number of nursing home residents on these drugs.

Family alleges long-term care facility banned them due to social media posts, ...

Family members of a Texas long-term care resident have sued the facility where she lives, claiming they were banned from visiting due to their social media posts, according to a publication covering legal proceedings in the state.